Shkreli Prosecutors Finish Four Weeks of Evidence, Trial Nears End
- ‘Pharma Bro’ accused of running hedge funds as Ponzi scheme
- Shkreli said Monday he won’t testify in his own defense
Martin Shkreli Faces Day of Reckoning in Court
This article is for subscribers only.
Prosecutors wrapped up their fraud case against Martin Shkreli after weeks of testimony that depicted the Retrophin Inc. co-founder as a Ponzi schemer who stole money from his hedge-fund investors to launch his drug company.
Shkreli’s lawyers rested their case as well on Wednesday. They didn’t offer any witnesses, relying instead on intense cross-examination during the government’s case. Shkreli didn’t testify. Jurors may begin deliberating by week’s end after hearing arguments from the lawyers on Thursday.